Skip to main content
OpenTrials
Completed

NCT Number: NCT06059170

Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life

Quality of life and risk factors for developing major LARS are explored. Therapeutic options were explored in the cohort experiencing major LARS

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rectal Cancer Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Low Anterior Resection Syndrome Neoplasms Neoplasms by Site Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Rectal Diseases Rectal Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University hospital Ghent

Ghent, Oost-Vlaanderen, 9000, Belgium

About this study

Quality of life and risk factors for developing major LARS are explored using the EORTC QLQ C30. Therapeutic options were explored in the cohort experiencing major LARS

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • low anterior resection for rectal cancer between 2006-2016
  • Adults

Exclusion criteria

  • abdomino perineal resection
  • patients who do not understand Dutch

Treatment and study plan

LARS score/ EORTC QLQ C30

Behavioral

administering questionnaire

Primary outcomes

  1. Assessment QoL

    Time frame: up to 10 years after rectal resection

    Assessments using questionnaire European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ C30)

  2. frequencies of therapeutic options to manage LARS

    Time frame: up to 10 years after rectal resection

    Self developed questionaire to determine what therapeutic options were used to manage LARS

  3. Frequency of LARS

    Time frame: up to 10 years after rectal resection

    Assessment of LARS using validated LARS Score

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Sep 28, 2023
Registry last updated
Sep 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.